{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:52:01Z","timestamp":1788983521920,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001832","name":"Sage Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002736","name":"Citizens United for Research in Epilepsy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001008","name":"Brinson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-MH106512"],"award-info":[{"award-number":["R01-MH106512"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-MH062500"],"award-info":[{"award-number":["R01-MH062500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH111790"],"award-info":[{"award-number":["R01MH111790"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG049002"],"award-info":[{"award-number":["R01-AG049002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jneuroim.2020.577324","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:04:44Z","timestamp":1594958684000},"page":"577324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitis"],"prefix":"10.1016","volume":"347","author":[{"given":"George","family":"Culler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"VanHaerents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577324_bb0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(66)92876-5","article-title":"Hashimoto\u2019s disease and encephalopathy","volume":"2","author":"Brain","year":"1966","journal-title":"Lancet (Lond. Eng.)"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0010","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000130","article-title":"Earlier treatment of nmdar antibody encephalitis in children results in a better outcome","volume":"2","author":"Byrne","year":"2015","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1590\/S0004-27302013000300005","article-title":"Utiliza\u00e7\u00e3o dos testes de fun\u00e7\u00e3o tireoidiana na pr\u00e1tica cl\u00ednica","volume":"57","author":"de Carvalho","year":"2013","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.07.009","article-title":"Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction","volume":"323","author":"Dubey","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/epi.14649","article-title":"Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability","volume":"60","author":"Dubey","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jns.2003.09.007","article-title":"Hashimoto\u2019s encephalopathy: epidemiologic data and pathogenetic considerations","volume":"217","author":"Ferracci","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0060","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","article-title":"Autoimmune epilepsy","volume":"16","author":"Husari","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0065","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2007.11.004","article-title":"CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis","volume":"268","author":"Jarius","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0080","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0036-1585453","article-title":"Autoantibody-associated central nervous system neurologic disorders","volume":"36","author":"Linnoila","year":"2016","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/ane.12556","article-title":"Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT","volume":"134","author":"Litmeier","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0095","series-title":"Improving the Antibody-Based Evaluation of Autoimmune Encephalitis","first-page":"1","volume":"0","author":"Mccracken","year":"2017"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0100","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","article-title":"Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0105","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0110","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0115","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2967\/jnumed.116.184333","article-title":"Diagnostic value of 18 F-FDG PET\/CT versus MRI in the setting of antibody-specific autoimmune encephalitis","volume":"58","author":"Solnes","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0120","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-510X(99)00163-X","article-title":"Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody","volume":"168","author":"Tanaka","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577324_bb0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2020.577324_bb0135","series-title":"Evaluation of Clinical and Paraclinical Findings for the Differential Diagnosis of Autoimmune and Infectious Encephalitis","first-page":"1","volume":"9","author":"Wagner","year":"2018"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820301934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820301934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:37:38Z","timestamp":1759048658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820301934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"alternative-id":["S0165572820301934"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577324","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577324"}}